Literature DB >> 704514

Diagnosis and natural history of congested (dilated) cardiomyopathies.

C Oakley.   

Abstract

The diagnosis of primary dilated cardiomyopathy depends on the recognition of a dilated poorly contracting left ventricle with increased end-diastolic and end-systolic volumes in the absence of a detectable cause. The diagnosis is made only after exclusion both of structural heart disease and of known causes of secondary heart muscle disorder. The natural history is still largely unknown and is probably as variable as the likely causes. The left ventricular disorder does not cause symptoms until heart failure supervenes except for occasional patients who develop an early atrial or ventricular dysrhythmia, conduction defect, chest pain or murmur of mitral regurgitation. This period of latency may be short, prolonged or even permanent since it is unlikely that all cases progess to the point of failure. A few patients recover normal or near-normal cardiac function. The interplay between high blood pressure, hypertensive heart failure and dilated cardiomyopathy is illustrated by patients who recover from heart failure to become hypertensive and vice versa and in current treatment with vasodilators and diuretics for patients at either end of the spectrum.

Entities:  

Mesh:

Year:  1978        PMID: 704514      PMCID: PMC2425104          DOI: 10.1136/pgmj.54.633.440

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  ALCOHOLIC HEART DISEASE.

Authors:  W BRIGDEN; J ROBINSON
Journal:  Br Med J       Date:  1964-11-21

2.  Value of prolonged bed rest in management of cardiomegaly.

Authors:  G E BURCH; J J WALSH; W C BLACK
Journal:  JAMA       Date:  1963-01-12       Impact factor: 56.272

3.  Endomyocardial biopsy.

Authors:  S SAKAKIBARA; S KONNO
Journal:  Jpn Heart J       Date:  1962-11

Review 4.  The cardiomyopathies.

Authors:  J F Goodwin; C M Oakley
Journal:  Br Heart J       Date:  1972-06

5.  Clinical recognition of the cardiomyopathies.

Authors:  C M Oakley
Journal:  Circ Res       Date:  1974-08       Impact factor: 17.367

6.  Clinical definitions and classification of cardiomyopathies.

Authors:  C M Oakley
Journal:  Postgrad Med J       Date:  1972-12       Impact factor: 2.401

7.  Enzymic analysis of endomyocardial biopsy specimens from patients with cardiomyopathies.

Authors:  T J Peters; G Wells; C M Oakley; I A Brooksby; B S Jenkins; M M Webb-Peploe; D J Coltart
Journal:  Br Heart J       Date:  1977-12
  7 in total
  7 in total

Review 1.  The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure.

Authors:  Nicola Riccardo Pugliese; Stefano Masi; Stefano Taddei
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

2.  Prediction of outcome in dilated cardiomyopathy.

Authors:  R A Diaz; A Obasohan; C M Oakley
Journal:  Br Heart J       Date:  1987-10

3.  Relation between alcohol intake, myocardial enzyme activity, and myocardial function in dilated cardiomyopathy. Evidence for the concept of alcohol induced heart muscle disease.

Authors:  P J Richardson; A D Wodak; L Atkinson; J B Saunders; D E Jewitt
Journal:  Br Heart J       Date:  1986-08

4.  Assessment of heart neurons in dilated (congestive) cardiomyopathy.

Authors:  D S Amorim; E G Olsen
Journal:  Br Heart J       Date:  1982-01

Review 5.  Cardiomyopathies and myocardial disorders in Africa: present status and the way forward.

Authors:  A O Falase; O S Ogah
Journal:  Cardiovasc J Afr       Date:  2012-11       Impact factor: 1.167

6.  The Relationship Between Absence Coronary Artery Calcification and Myocardial Perfusion Single Photon Emission Computed Tomography.

Authors:  Muhannad Alanazi; Alaa AlDuraibi; Mohamamed M Shoukri; Ahmed Fathala
Journal:  Cardiol Res       Date:  2018-02-11

Review 7.  Coronary artery disease detection - limitations of stress testing in left ventricular dysfunction.

Authors:  Ritin Bomb; Senthil Kumar; Anand Chockalingam
Journal:  World J Cardiol       Date:  2017-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.